Faks
PrivateLast Round
VC Round
Mar 3, 2025
Total Funding Raised
$5.44M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Faks operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was a VC Round in March 2025.
Faks is a healthcare technology company that provides a SaaS platform designed to centralize and streamline communication and after-sales operations between pharmacies, pharmacy groups, and pharmaceutical laboratories.
Sector
Healthcare & Life Sciences
Verticals
Vertical SaaS, Workflow Automation, Pharma Supply Chain
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Faks Comparables
Compare Faks with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Winpharma | 81% | |
| Equasens Group | 76% | |
| La Source Informatique | 76% |
For institutional investors. Book with your work email.
Faks Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 3, 2025 | ||||
| Seed | May 17, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Faks Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Connect Ventures | Seed, VC Round |
| Speedinvest | VC Round |
| FJ Labs | VC Round |
| Cocoa Ventures | Seed |
| Seedcamp | Seed, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 130% MoM, reaching 19.5K.
- Jan 1, 2026
Claims all French pharmaceutical lab sales forces use its app.
For institutional investors. Book with your work email.
Faks Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Faks's valuation, stock price, and market status.
Is Faks a public or private company?
Faks is a private company.
What is the current stock price of Faks?
Faks is a private company, so its shares have no public market price. Caplight tracks Faks's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Faks worth (valuation)?
Valuation information for Faks is not publicly available.
Can I buy Faks stock?
Faks shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Faks's last funding round?
Faks's most recent funding round was VC Round on March 3, 2025.
Who are the main investors in Faks?
Key investors in Faks include Speedinvest.
Will Faks IPO soon?
No public IPO plans have been announced for Faks.
How can I track Faks secondary market activity?
Caplight tracks bids, offers, and trades in Faks's shares on secondary markets.